Kintai Therapeutics
Jan 23, 2020
Tepezza receives approval; a new way to treat Alzheimer’s
Horizon Therapeutics has become the first company to receive the regulatory approval of its drug Tepezza for the cure of Thyroid Eye Tepezza (teprotumumab-trbw) is the first-ever treatment approved for thyroid eye is a progressive autoimmune disorder hampering the ability of vision. The drug was approved under P...
Read More...
-Agonist.png "Toll-like Receptors Agonist")
